Summary
Alzheimer's disease (AD) is characterised by an increased number of senile plaques (SP) and neuroflbrillary tangles (NFT) as compared with that found in non-demented individuals of the same age, and a marked degeneration and loss of synapses. One of the main risk-factors for the disorder is inheritance of the apolipoprotein E4 (ApoE4) allele. To further study the relation between these pathogenetic substrates for AD, we quantified the synaptic vesicle membrane protein rab3a in brain tissue from 19 patients with AD and 9 age-matched control subjects. Rab3a levels were reduced in AD, both in the hippocampus (60% of control level, p < 0.0001), and in the frontal cortex (68% of control level, p < 0.01), but not in the cerebellum (92% of control level). Within the AD group, lower rab3a levels were found both with increasing duration and severity of dementia. These findings further support that synaptic pathology is closely correlated to the clinical dementia in AD. In contrast, no significant correlations were found between SP counts and duration or severity of dementia, while higher NFT counts in the frontal cortex were found with increasing severity of dementia (r=0.54, p < 0.05). There were no significant correlations between the rab3a level and SP or NFT counts, and by immunohistochemistry, reduced rab3a immunostaining was found throughout the neuropil in AD brain, without relation to SP or NFT. These findings suggest that the synaptic pathology in AD is not closely related to the presence of SP and NFT. No significant differences in rab3a levels were found in any brain region between AD patients possessing different numbers of the ApoE4 allele, suggesting that, although ApoE4 is a risk factor for earlier development of AD, the degree of synaptic pathology does not differ between patients with or without the ApoE4 allele.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Adolfsson R, Gottfries CG, Nyström L, Winblad B (1981) Prevalence of dementia in institutionalised Swedish old people: the work load imposed by caring for these patients. Acta Psychiatr Scand 63: 225–244
Alafuzoff I, Iqbal K, Fridén H, Adolfsson R, Winblad B (1987) Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol (Berl) 74: 209–225
Andersen P, Bliss TVP, Skrede KK (1971) Lamellar organization of hippocampus excitatory pathways. Exp Brain Res 13: 222–238
Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 4: 631–639
Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114: 797–811
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921–923
Davies CA, Mann DMA, Sumpter PQ, Yates PO (1987) A quantitative morphometric analysis of the synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 78: 151–164
DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27: 457–464
Dickson DW, Crystal HA, Benova C, Honer W, Vincent I, Davies P (1995) Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 16: 285–304
Duyckaerts C, Hauw JJ, Bastenaire F, Piette F, Poulain C, Rainsard V, Javoy-Agid F, Berthaux P (1986) Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol (Berl) 70: 249–256
Fischer von Mollard G, Mignery GA, Baumert M, Burger PR, Perin M, Jahn R, Südhof TC (1990) Rab3 is a small GTP-binding protein exclusively localised to synaptic vesicles. Proc Natl Acad Sci USA 87: 1988–1992
Gearing M, Schneider JA, Robbins RS, Hollister RD, Mori H, Games D, Hyman BT, Mirra SS (1995) Regional variation in the distribution of apolipoprotein E and Aβ in Alzheimer's disease. J Neuropathol Exp Neurol 54: 833–841
Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of purification and characterisation of a novel cerebrovascular amyloid protein. Biochem Biophys Res Comm 120: 885–890
Hamos JE, DeGennaro LJ, Drachman DA (1989) Synaptic loss in Alzheimer's disease and other dementias. Neurology 39: 355–361
Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12: 383–388
Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM (1994) Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Am J Pathol 145: 1472–1484
Heinonen O, Soininen H, Sorvari H, Kosunen O, Paljärvi L, Koivisto E, Riekkinen PJ (1995) Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neuroscience 64: 375–384
Honer WG, Dickson DW, Gleeson J, Davies P (1992) Regional synaptic pathology in Alzheimer's disease. Neurobiol Aging 13: 375–382
Hoyer S (1993) Sporadic dementia of Alzheimer's disease: role of amyloid in the etiology is challenged. J Neural Transm [P-D Sect] 6: 159–165
Jahn R, Südhof TC (1993) Synaptic vesicle traffic: rush hour in the nerve terminal. J Neurochem 61: 12–21
Joachim CL, Selkoe DJ (1992) The seminal role of β-amyloid in the pathogenesis of Alzheimer's disease. Alzheimer Dis Assoc Disord 6: 7–34
Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Müller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733–736
Kida E, Golabek AA, Wisniewski T, Wisniewski KE (1994) Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease. Neurosci Lett 167: 73–76
Laemmli UK (1972) Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 227: 680–685
Lassman H, Weiler R, Fischer P, Bancher C, Jellinger K, Floor E, Danielczyk W, Scitelberger F, Winkler H (1992) Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles. Neuroscience 46: 1–8
Leary JJ, Brigati DJ, Ward DC (1983) Rapid and sensitive colorimetric method for visualizing biotin-labelled DNA probes hybridized to DNA or RNA immobilized in nitrocellulose Bio-Blots. Proc Natl Acad Sci USA 80: 4045–4049
Lledo PM, Johannes L, Vernier P, Zorec R, Darchen F, Vincent JD, Henry JP, Mason WT (1994) Rab3a proteins: key players in the control of exocytosis. TINS 17: 426–432
Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622–630
Masliah E, Terry RD, Alford M, De Teresa R, Hansen LA (1991a) Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. Am J Pathol 138: 235–246
Masliah E, Hansen L, Albright T, Mallory M, Terry RD (1991b) Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease. Acta Neuropathol 81: 428–433
Masliah E, Mallory M, Hansen L, De Teresa R, Terry RD (1993) Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 43: 192–197
Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc Natl Acad Sci 82: 4245–4249
Matteoli M, Takei K, Cameron R, Hurlkbut P, Johnston PA, Sudhof TC, Jahn R, De Camilli P (1991) Association of rab3a with synaptic vesciles at late stages of the secretory pathway. J Cell Biol 115: 625–633
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34: 939–944
Miller A, Alford M, Katzman R, Thai L, Saitoh T, Masliah E (1994) The expression of the Apo-ɛ4 allele in Alzheimlr's disease accentuates the synaptic loss and the severity of the dementia (Abstract). Ann Neurol 36: 268–269
Morimatsu M, Hirai S, Muramatsu A, Yoshikawa M (1975) Senile degenerative brain lesions and dementia. J Am Geriatr Soc 23: 390–406
Morris JC, McKeel DW, Strorandt M (1991) Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 41: 469–478
Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541: 163–166
Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264: 850–852
Perry EK (1994) Cholinergic component of cognitive impairment in dementia. In: Burns A, Levy R (eds) Dementia. Chapman & Hall, London, pp 143–157
Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697–699
Poirier J (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. TINS 17: 525–530
Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11: 575–580
Regland B, Gottfries CG (1992) The role of amyloid β-protein in Alzheimer's disease. Lancet 340: 467–469
Roth M (1986) The association of clinical and neurological findings and its bearing on the classification and aetiology of Alzheimer's disease. Br Med Bull 42: 42–50
Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Grain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele ɛ4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467–1472
Scheff SW, Sparks DL, Price DA (1993) Quantitative assessment of synaptic density in the entorhinal cortex in Alzheimer's disease. Ann Neurol 34: 356–361
Schmechel D, Saunders AM, Strittmatter WJ, Crain B, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 90: 9649–9653
Selkoe DJ (1994) Alzhemier's disease: a central role for amyloid. J Neuropathol Exp Neurol 53: 438–447
Smith PK, Krohn RI, Hermansson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76–85
Snipes GJ, McGuire CB, Norden JJ, Freeman JA (1986) Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. Proc Natl Acad Sci USA 83: 1130–1134
Soininen H, Kosunen O, Helisalmi S, Mannermaa A, Paljärvi L, Talasniemi S, Ryynänen M, Riekkinen Sr P (1995) A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein ɛ4 allele. Neurosci Lett 187: 79–82
Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimers disease. Proc Natl Acad Sci USA 90: 1977–1981
Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong LM, Jakes R, Alberts MJ, Gilbert JR, Han SH, Hulette C, Einstein G, Schmechel D, Pericak-Vance MA, Roses AD (1994) Hypothesis: microtubule instability and paired helical filaments formation in the Alzheimers disease brain are related to apolipoprotein E genotype. Exp Neurol 125: 163–171
Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30: 572–580
Tomlinson BE, Corsellis JAN (1984) Ageing in the dementias. In: Hume Adams J, Corsellis JAN, Duchen LW (eds) Greenfield's neuropathology. Edward Arnold, London, pp 951–1025
Wilcock GK, Esiri MM (1982) Plaques, tangles and dementia: a quantitative study. J Neurol Sci 56: 343–356
Wisniewski T, Frangione B (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135: 235–238
Zhan SS, Beyreuther K, Schmitt HP (1993) Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia. Dementia 4: 66–74
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blennow, K., Bogdanovic, N., Alafuzoff, I. et al. Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. J. Neural Transmission 103, 603–618 (1996). https://doi.org/10.1007/BF01273157
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01273157